Pediatrics News

The number of babies who accidentally die from suffocation because they sleep with their parents or other caregivers remains stubbornly high in Connecticut. A big reason is parents, many of them single caregivers, who need to calm a baby to get a decent night’s sleep because they need to get to work in the morning.

A Yale health expert is raising awareness of measles as cases are reported in New York and New Jersey. Dr. Magna Dias, a professor of pediatrics at Yale School of Medicine says the U.S. typically sees a few cases of measles each year from unvaccinated travelers coming into the country.

On April 5, Yale Pediatricians hosted a POCUS (point-of-care ultrasound) Workshop at Yale's West Campus.

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

Drug overdoses are one of the main causes of preventable death among pregnant and postpartum women in the United States. Overdose deaths among this population increased 81% between 2017 and 2020 — resulting in the deaths of more than 1,200 pregnant and postpartum women in 2020. Yet limited resources and stigma prevent pregnant women who struggle with substance use from seeking or accessing care. Those who do seek care and start taking medications to assist their recovery, like Puccio, are often reported to welfare services for child abuse and neglect under legal mandate. But in some hospitals, the response is changing.

If TikTok has you stressed about your baby’s sleep schedule, you aren’t alone.

April has been designated Child Abuse Prevention Month in the United States since 1983.

A multidisciplinary team of Yale scientists has received a $4-million federal grant to study the effectiveness of a new vaccine and monoclonal antibody shot designed to prevent respiratory syncytial virus (RSV) in infants.